SQI Diagnostics Inc. announced that Dr. Eric Brouwer has been appointed Interim Chief Executive Officer to replace Andrew Morris. Mr. Morris will continue on as a director of the Company and will take on an advisory role for up to one year. The effective date of this transition is February 14, 2020.

Prior to joining SQI Dr. Brouwer was the CSO of Trinity Biotech and CEO of Fiomi Diagnostics, Trinity Biotech's Swedish subsidiary. Dr. Brouwer will continue to implement the company's current scientific strategy and commercialization of a suite of exciting diagnostics solutions. In addition, the Company also announced that Patricia Lie, the Vice President Finance and Administration, has resigned effective December 31, 2019.